Key Points
- Michelle Link sold 4,039 shares for $350,746.76 on Dec. 3, cutting her stake to 19,542 shares — a 17.13% reduction in ownership.
- Maximus reported Q3 EPS of $1.62 (missing estimates by $0.01) and revenue of $1.32B versus $1.34B expected, and set FY2026 guidance of $7.95–$8.25 EPS while analysts project ~6.15 EPS for the current year.
- The company paid a $0.30 quarterly dividend (annualized yield ~1.4%), the stock was trading down ~1.9% near $84.85 with a $4.62B market cap, and institutional investors own 97.21% of shares while the consensus target is $90.
Maximus, Inc. (NYSE:MMS - Get Free Report) insider Michelle Link sold 4,039 shares of the business's stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the sale, the insider directly owned 19,542 shares of the company's stock, valued at $1,697,027.28. This represents a 17.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Maximus Trading Down 1.9%
MMS stock opened at $84.85 on Thursday. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.77. The company has a market cap of $4.62 billion, a price-to-earnings ratio of 15.26 and a beta of 0.56. The business has a fifty day simple moving average of $85.56 and a 200-day simple moving average of $80.24. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $92.50.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.01). The firm had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.34 billion. Maximus had a return on equity of 25.23% and a net margin of 5.87%.During the same quarter in the prior year, the company earned $1.46 earnings per share. The business's revenue was up .2% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. On average, equities research analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.
Maximus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 1st. Stockholders of record on Friday, November 14th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, November 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus's dividend payout ratio is presently 21.58%.
Institutional Trading of Maximus
Several institutional investors have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP raised its position in shares of Maximus by 2.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider's stock worth $170,812,000 after purchasing an additional 36,989 shares during the period. Fuller & Thaler Asset Management Inc. raised its stake in shares of Maximus by 40.0% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider's stock worth $117,921,000 after buying an additional 494,372 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of Maximus by 177.2% during the 1st quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider's stock valued at $79,341,000 after purchasing an additional 750,031 shares in the last quarter. Boston Partners boosted its holdings in Maximus by 47.0% during the third quarter. Boston Partners now owns 966,139 shares of the health services provider's stock worth $88,236,000 after buying an additional 308,892 shares in the last quarter. Finally, Reinhart Partners LLC. grew its holdings in shares of Maximus by 0.8% in the 3rd quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider's stock worth $84,206,000 after acquiring an additional 7,722 shares during the last quarter. Institutional investors own 97.21% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on the stock. Weiss Ratings upgraded shares of Maximus from a "hold (c+)" rating to a "buy (b-)" rating in a report on Tuesday. Zacks Research cut Maximus from a "strong-buy" rating to a "hold" rating in a research note on Monday, October 27th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $90.00.
Get Our Latest Stock Analysis on MMS
Maximus Company Profile
(
Get Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
